244 related articles for article (PubMed ID: 33062716)
1. Alterations of Gut Microbiota in Type 2 Diabetes Individuals and the Confounding Effect of Antidiabetic Agents.
Almugadam BS; Liu Y; Chen SM; Wang CH; Shao CY; Ren BW; Tang L
J Diabetes Res; 2020; 2020():7253978. PubMed ID: 33062716
[TBL] [Abstract][Full Text] [Related]
2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
3. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
4. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
5. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
8. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
9. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
10. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.
Alvarez-Silva C; Kashani A; Hansen TH; Pinna NK; Anjana RM; Dutta A; Saxena S; Støy J; Kampmann U; Nielsen T; Jørgensen T; Gnanaprakash V; Gnanavadivel R; Sukumaran A; Rani CSS; Færch K; Radha V; Balasubramanyam M; Nair GB; Das B; Vestergaard H; Hansen T; Mande SS; Mohan V; Arumugam M; Pedersen O
Genome Med; 2021 Mar; 13(1):37. PubMed ID: 33658058
[TBL] [Abstract][Full Text] [Related]
11. Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats.
Zhang Q; Xiao X; Zheng J; Li M; Yu M; Ping F; Wang T; Wang X
Exp Biol Med (Maywood); 2018 Jan; 243(1):34-44. PubMed ID: 29171288
[TBL] [Abstract][Full Text] [Related]
12. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
Zhang L; Luo J; Li X; Guo S; Shi D
Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
[TBL] [Abstract][Full Text] [Related]
13. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
[TBL] [Abstract][Full Text] [Related]
14. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
Zhang W; Xu JH; Yu T; Chen QK
Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
[TBL] [Abstract][Full Text] [Related]
15. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals.
Sedighi M; Razavi S; Navab-Moghadam F; Khamseh ME; Alaei-Shahmiri F; Mehrtash A; Amirmozafari N
Microb Pathog; 2017 Oct; 111():362-369. PubMed ID: 28912092
[TBL] [Abstract][Full Text] [Related]
16. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
17. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus.
Liu W; Luo Z; Zhou J; Sun B
Front Cell Infect Microbiol; 2022; 12():853771. PubMed ID: 35711668
[TBL] [Abstract][Full Text] [Related]
19. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
20. Obese Individuals With and Without Phlegm-Dampness Constitution Show Different Gut Microbial Composition Associated With Risk of Metabolic Disorders.
Shin J; Li T; Zhu L; Wang Q; Liang X; Li Y; Wang X; Zhao S; Li L; Li Y
Front Cell Infect Microbiol; 2022; 12():859708. PubMed ID: 35719350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
